$6.51
0.06%
Nasdaq, Oct 15, 02:09 pm EDT. Closed.
ISIN
US98978N2009
Symbol
ZIVO

Zivo Bioscience Inc Stock price

$6.51
+2.41 58.87% 1M
+4.29 192.35% 6M
-2.19 25.13% YTD
-6.94 51.57% 1Y
+1.83 39.00% 3Y
-18.39 73.84% 5Y
-26.61 80.33% 10Y
-627.09 98.97% 20Y
Nasdaq, Closing price Thu, Oct 15 2026
+0.00 0.00%
ISIN
US98978N2009
Symbol
ZIVO

Is Zivo Bioscience Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,109 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
$480.0k
Cash
$60.0k
Shares outstanding
3.8m
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
- | -
P/B
-
Financial Health
Equity Ratio
-31.3%
Return on Equity
2,599.5%
ROCE
277.3%
ROIC
-
Debt/Equity
-0.2
Share-Based Compensation & Dilution
SBC | % of Revenue
$1.7m | 814.3%
SBC as % of FCF
-
SBC Growth 1Y
-80.8%
Share Count Growth 1Y
9.7%
Shareholder Yield
-9.7%
Financials
Revenue | estimate
$210.0k | $217.3k
EBITDA
-
EBIT
$-8.5m
Net Income
$-8.5m
Free Cash Flow | ex SBC
$-3.1m | $-4.8m
Growth
Revenue | estimate
162.5% | 35.8%
EBITDA
-
EBIT
38.1%
Net Income
38.0%
Free Cash Flow
25.4%
Margin
Gross
31.7%
EBITDA
-
EBIT
-4,046.1%
Net
-4,060.2%
Free Cash Flow | ex SBC
-1,473.2% | -2,291.0%
More
EPS
$-2.2
FCF per Share
$-0.8
Short interest
4.0%
Employees
7
Rev per Employee
$20.0k

Zivo Bioscience Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Zivo Bioscience Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Zivo Bioscience Inc forecast:

Hold
50%
Sell
50%

Financial data from Zivo Bioscience Inc

Sep '25
+/-
%
0.21 0.21
163% 163%
100%
- Direct Costs 0.14 0.14
180% 180%
67%
0.07 0.07
133% 133%
33%
- Selling and Administrative Expenses 4.83 4.83
54% 54%
2,300%
- Research and Development Expense 3.70 3.70
16% 16%
1,762%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -8.46 -8.46
38% 38%
-4,027%
Net Profit -8.49 -8.49
38% 38%
-4,043%

In millions USD.

Don't miss a Thing! We will send you all news about Zivo Bioscience Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zivo Bioscience Inc Stock News

Neutral
Business Wire
●
5 months ago
TROY, Mich.--(BUSINESS WIRE)--Zivo Bioscience, Inc. (OTCID: ZIVO) ("ZIVO" or the "Company") announced today that it is transitioning its common stock to quotation on the OTCID marketplace. Zivo Bioscience began trading on OTCID as of Monday, May 11, 2026. Transitioning to OTCID is a common step for companies seeking to maintain public trading while aligning with a marketplace that offers stream...

Company Profile

Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Keego Harbor, MI.

Head office United States
CEO John Payne
Employees 7
Founded 1983
Website zivobioscience.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today